The system was tested by (1) determining specificity and sensitivity in SSc cases and controls with scleroderma-like disorders, and (2) validating against the combined view of a group of experts on a ...
AND (“autoimmun*” OR autoaggressive OR autoantibody OR lupus OR rheuma* OR Addison* OR celiac OR “gluten sensitive” OR dermatomyositis OR Hashimoto OR graves OR sclerosis OR scleroderma OR myasthenia ...
134 A phase II study investigating B-cell depletion with rituximab (monoclonal antibody against CD20) in scleroderma-PAH is underway (NCT01086540). Mitochondrial abnormalities with a metabolic switch ...